Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement

Thrombosis and Haemostasis

Volumn 112, Issue 6, 2014, Pages 1120-1128

  Mathew, Joseph G ^a   Spyropoulos, Alex C ^b   Yusuf, Arif ^a   Vincent, Jessica ^a   Eikelboom, John ^a,g   Shestakovska, Olga ^a   Fremes, Stephen ^c   Noora, Joseph ^d   Guo, Linrui ^e   Peterson, Mark ^f   Pai, Menaka ^g   Whitlock, Richard ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d CREDIT VALLEY HOSPITAL   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulants; Cardiac surgery; Heparin; Thromboembolism; Valvular heart diseases

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ADULT; ANTICOAGULATION; ARTERIAL THROMBOEMBOLISM; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEEP VEIN THROMBOSIS; FEMALE; HEART VALVE REPLACEMENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MECHANICAL HEART VALVE; OUTCOME ASSESSMENT; PROPHYLAXIS; PROSTHETIC VALVE THROMBOSIS; RETROSPECTIVE STUDY; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; AGED; CANADA; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; DRUG ADMINISTRATION; HEART VALVE PROSTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MULTICENTER STUDY; PROPENSITY SCORE; PROSTHESIS; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STROKE; TIME;

ADMINISTRATION, INTRAVENOUS; AGED; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEPARIN; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; ONTARIO; PROPENSITY SCORE; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 84914166402     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-03-0284     Document Type: Article

References (17)

1. Mok CK, Boey J, Wang R, et al. Warfarin versus dipyridamole- aspirin and pent-oxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation 1985; 72: 1059–1063.
2. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635–641.
3. Butchart EG, Gohlke-Bärwolf C, Antunes MJ, et al.; Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005; 26: 2463–2471.
4. Whitlock RP, Sun JC, Fremes SE, et al.; American College of Chest Physicians. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e576S-600S.
5. Bonow RO, Carabello BA, Chatterjee K, et al.; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:e1–142.
6. Kulik A, Rubens FD, Baird D, et al. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey. J Heart Valve Dis 2006; 15: 581–587.
7. Austin PC. Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review. Circ Cardiovasc Qual Outcomes 2008; 1: 62–67.
8. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46: 399–424.
9. Heinze G, Jüni P. An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J 2011; 32: 1704–1708.
10. Kulik A, Rubens FD, Wells PS, et al. Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg 2006; 81: 770–781.
11. Ageno W, Turpie AG, Steidl L, et al. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement. Am J Cardiol 2001; 88: 40–44.
12. Montalescot G, Polle V, Collet J P, Leprince P, Bellanger A, Gandjbakhch I, Thomas D.. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000; 101: 1083–1086.
13. Fanikos J, Tsilimingras K, Kucher N, et al. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol 2004; 93: 247–250.
14. Iliuta L, Candea V, Vasilescu A, et al. Fraxiparine versus unfractionated heparin for the perioperative anticoagulant therapy in patients undergoing mechanical prosthetic heart valve replacement. Arch Union Med Balkan 2003; 38: 141–148.
15. Spyropoulos AC, Turpie AG, Dunn AS, et al.; REGIMEN Investigators. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol 2008; 102: 883–88
16. Siegal D, Yudin J, Kaatz S, et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126: 1630–1639.
17. Birnie DH, Healey JS, Wells GA, et al.; BRUISE CONTROL Investigators. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 2013; 368: 2084–2093.